Global Influenza Drugs Sales Market Report 2021

Publisher Name :
Date: 05-May-2021
No. of pages: 143
Inquire Before Buying

The global Influenza Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Influenza Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.

Segment by Type

- Zanamivir

- Oseltamivir Phosphate

- Peramivir

- Other Influenza Drugs

Segment by Application

- Adults

- Chidren

The Influenza Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Influenza Drugs market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.

By Company

- Bristol-Myers Squibb]

- AstraZeneca

- Eli Lilly

- Roche

- GlaxoSmithKline

- Novartis

- Pfizer

- Sanofi Pasteur

- Bayer

- Celgene

- Seqirus

- Protein Sciences Corporation

- Serum Institute of India

- Emergent Biosolutions

- BioCryst Pharmaceuticals

- Alvogen

Global Influenza Drugs Sales Market Report 2021

Table of Contents
1 Influenza Drugs Market Overview
1.1 Influenza Drugs Product Scope
1.2 Influenza Drugs Segment by Type
1.2.1 Global Influenza Drugs Sales by Type (2016 & 2021 & 2027)
1.2.2 Zanamivir
1.2.3 Oseltamivir Phosphate
1.2.4 Peramivir
1.2.5 Other Influenza Drugs
1.3 Influenza Drugs Segment by Application
1.3.1 Global Influenza Drugs Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Adults
1.3.3 Chidren
1.4 Influenza Drugs Market Estimates and Forecasts (2016-2027)
1.4.1 Global Influenza Drugs Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Influenza Drugs Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Influenza Drugs Price Trends (2016-2027)
2 Influenza Drugs Estimates and Forecasts by Region
2.1 Global Influenza Drugs Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Influenza Drugs Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Influenza Drugs Sales Market Share by Region (2016-2021)
2.2.2 Global Influenza Drugs Revenue Market Share by Region (2016-2021)
2.3 Global Influenza Drugs Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Influenza Drugs Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Influenza Drugs Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Influenza Drugs Estimates and Projections (2016-2027)
2.4.2 Europe Influenza Drugs Estimates and Projections (2016-2027)
2.4.3 China Influenza Drugs Estimates and Projections (2016-2027)
2.4.4 Japan Influenza Drugs Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Influenza Drugs Estimates and Projections (2016-2027)
2.4.6 India Influenza Drugs Estimates and Projections (2016-2027)
3 Global Influenza Drugs Competition Landscape by Players
3.1 Global Top Influenza Drugs Players by Sales (2016-2021)
3.2 Global Top Influenza Drugs Players by Revenue (2016-2021)
3.3 Global Influenza Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Influenza Drugs as of 2020)
3.4 Global Influenza Drugs Average Price by Company (2016-2021)
3.5 Manufacturers Influenza Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Influenza Drugs Market Size by Type
4.1 Global Influenza Drugs Historic Market Review by Type (2016-2021)
4.1.1 Global Influenza Drugs Sales Market Share by Type (2016-2021)
4.1.2 Global Influenza Drugs Revenue Market Share by Type (2016-2021)
4.1.3 Global Influenza Drugs Price by Type (2016-2021)
4.2 Global Influenza Drugs Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Influenza Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Influenza Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Global Influenza Drugs Price Forecast by Type (2022-2027)
5 Global Influenza Drugs Market Size by Application
5.1 Global Influenza Drugs Historic Market Review by Application (2016-2021)
5.1.1 Global Influenza Drugs Sales Market Share by Application (2016-2021)
5.1.2 Global Influenza Drugs Revenue Market Share by Application (2016-2021)
5.1.3 Global Influenza Drugs Price by Application (2016-2021)
5.2 Global Influenza Drugs Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Influenza Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Influenza Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Influenza Drugs Price Forecast by Application (2022-2027)
6 North America Influenza Drugs Market Facts & Figures
6.1 North America Influenza Drugs Sales by Company
6.1.1 North America Influenza Drugs Sales by Company (2016-2021)
6.1.2 North America Influenza Drugs Revenue by Company (2016-2021)
6.2 North America Influenza Drugs Sales Breakdown by Type
6.2.1 North America Influenza Drugs Sales Breakdown by Type (2016-2021)
6.2.2 North America Influenza Drugs Sales Breakdown by Type (2022-2027)
6.3 North America Influenza Drugs Sales Breakdown by Application
6.3.1 North America Influenza Drugs Sales Breakdown by Application (2016-2021)
6.3.2 North America Influenza Drugs Sales Breakdown by Application (2022-2027)
7 Europe Influenza Drugs Market Facts & Figures
7.1 Europe Influenza Drugs Sales by Company
7.1.1 Europe Influenza Drugs Sales by Company (2016-2021)
7.1.2 Europe Influenza Drugs Revenue by Company (2016-2021)
7.2 Europe Influenza Drugs Sales Breakdown by Type
7.2.1 Europe Influenza Drugs Sales Breakdown by Type (2016-2021)
7.2.2 Europe Influenza Drugs Sales Breakdown by Type (2022-2027)
7.3 Europe Influenza Drugs Sales Breakdown by Application
7.3.1 Europe 143 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 143 Sales Breakdown by Application (2022-2027)
8 China Influenza Drugs Market Facts & Figures
8.1 China Influenza Drugs Sales by Company
8.1.1 China Influenza Drugs Sales by Company (2016-2021)
8.1.2 China Influenza Drugs Revenue by Company (2016-2021)
8.2 China Influenza Drugs Sales Breakdown by Type
8.2.1 China Influenza Drugs Sales Breakdown by Type (2016-2021)
8.2.2 China Influenza Drugs Sales Breakdown by Type (2022-2027)
8.3 China Influenza Drugs Sales Breakdown by Application
8.3.1 China 168 Sales Breakdown by Application (2016-2021)
8.3.2 China 168 Sales Breakdown by Application (2022-2027)
9 Japan Influenza Drugs Market Facts & Figures
9.1 Japan Influenza Drugs Sales by Company
9.1.1 Japan Influenza Drugs Sales by Company (2016-2021)
9.1.2 Japan Influenza Drugs Revenue by Company (2016-2021)
9.2 Japan Influenza Drugs Sales Breakdown by Type
9.2.1 Japan Influenza Drugs Sales Breakdown by Type (2016-2021)
9.2.2 Japan Influenza Drugs Sales Breakdown by Type (2022-2027)
9.3 Japan Influenza Drugs Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Influenza Drugs Market Facts & Figures
10.1 Southeast Asia Influenza Drugs Sales by Company
10.1.1 Southeast Asia Influenza Drugs Sales by Company (2016-2021)
10.1.2 Southeast Asia Influenza Drugs Revenue by Company (2016-2021)
10.2 Southeast Asia Influenza Drugs Sales Breakdown by Type
10.2.1 Southeast Asia Influenza Drugs Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Influenza Drugs Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Influenza Drugs Sales Breakdown by Application
10.3.1 Southeast Asia K MT Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K MT Sales Breakdown by Application (2022-2027)
11 India Influenza Drugs Market Facts & Figures
11.1 India Influenza Drugs Sales by Company
11.1.1 India Influenza Drugs Sales by Company (2016-2021)
11.1.2 India Influenza Drugs Revenue by Company (2016-2021)
11.2 India Influenza Drugs Sales Breakdown by Type
11.2.1 India Influenza Drugs Sales Breakdown by Type (2016-2021)
11.2.2 India Influenza Drugs Sales Breakdown by Type (2022-2027)
11.3 India Influenza Drugs Sales Breakdown by Application
11.3.1 India Influenza Drugs Sales Breakdown by Application (2016-2021)
11.3.2 India Influenza Drugs Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Influenza Drugs Business
12.1 Bristol-Myers Squibb]
12.1.1 Bristol-Myers Squibb] Corporation Information
12.1.2 Bristol-Myers Squibb] Business Overview
12.1.3 Bristol-Myers Squibb] Influenza Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Bristol-Myers Squibb] Influenza Drugs Products Offered
12.1.5 Bristol-Myers Squibb] Recent Development
12.2 AstraZeneca
12.2.1 AstraZeneca Corporation Information
12.2.2 AstraZeneca Business Overview
12.2.3 AstraZeneca Influenza Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 AstraZeneca Influenza Drugs Products Offered
12.2.5 AstraZeneca Recent Development
12.3 Eli Lilly
12.3.1 Eli Lilly Corporation Information
12.3.2 Eli Lilly Business Overview
12.3.3 Eli Lilly Influenza Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Eli Lilly Influenza Drugs Products Offered
12.3.5 Eli Lilly Recent Development
12.4 Roche
12.4.1 Roche Corporation Information
12.4.2 Roche Business Overview
12.4.3 Roche Influenza Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Roche Influenza Drugs Products Offered
12.4.5 Roche Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Corporation Information
12.5.2 GlaxoSmithKline Business Overview
12.5.3 GlaxoSmithKline Influenza Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 GlaxoSmithKline Influenza Drugs Products Offered
12.5.5 GlaxoSmithKline Recent Development
12.6 Novartis
12.6.1 Novartis Corporation Information
12.6.2 Novartis Business Overview
12.6.3 Novartis Influenza Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Novartis Influenza Drugs Products Offered
12.6.5 Novartis Recent Development
12.7 Pfizer
12.7.1 Pfizer Corporation Information
12.7.2 Pfizer Business Overview
12.7.3 Pfizer Influenza Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Pfizer Influenza Drugs Products Offered
12.7.5 Pfizer Recent Development
12.8 Sanofi Pasteur
12.8.1 Sanofi Pasteur Corporation Information
12.8.2 Sanofi Pasteur Business Overview
12.8.3 Sanofi Pasteur Influenza Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Sanofi Pasteur Influenza Drugs Products Offered
12.8.5 Sanofi Pasteur Recent Development
12.9 Bayer
12.9.1 Bayer Corporation Information
12.9.2 Bayer Business Overview
12.9.3 Bayer Influenza Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Bayer Influenza Drugs Products Offered
12.9.5 Bayer Recent Development
12.10 Celgene
12.10.1 Celgene Corporation Information
12.10.2 Celgene Business Overview
12.10.3 Celgene Influenza Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Celgene Influenza Drugs Products Offered
12.10.5 Celgene Recent Development
12.11 Seqirus
12.11.1 Seqirus Corporation Information
12.11.2 Seqirus Business Overview
12.11.3 Seqirus Influenza Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Seqirus Influenza Drugs Products Offered
12.11.5 Seqirus Recent Development
12.12 Protein Sciences Corporation
12.12.1 Protein Sciences Corporation Corporation Information
12.12.2 Protein Sciences Corporation Business Overview
12.12.3 Protein Sciences Corporation Influenza Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Protein Sciences Corporation Influenza Drugs Products Offered
12.12.5 Protein Sciences Corporation Recent Development
12.13 Serum Institute of India
12.13.1 Serum Institute of India Corporation Information
12.13.2 Serum Institute of India Business Overview
12.13.3 Serum Institute of India Influenza Drugs Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Serum Institute of India Influenza Drugs Products Offered
12.13.5 Serum Institute of India Recent Development
12.14 Emergent Biosolutions
12.14.1 Emergent Biosolutions Corporation Information
12.14.2 Emergent Biosolutions Business Overview
12.14.3 Emergent Biosolutions Influenza Drugs Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Emergent Biosolutions Influenza Drugs Products Offered
12.14.5 Emergent Biosolutions Recent Development
12.15 BioCryst Pharmaceuticals
12.15.1 BioCryst Pharmaceuticals Corporation Information
12.15.2 BioCryst Pharmaceuticals Business Overview
12.15.3 BioCryst Pharmaceuticals Influenza Drugs Sales, Revenue and Gross Margin (2016-2021)
12.15.4 BioCryst Pharmaceuticals Influenza Drugs Products Offered
12.15.5 BioCryst Pharmaceuticals Recent Development
12.16 Alvogen
12.16.1 Alvogen Corporation Information
12.16.2 Alvogen Business Overview
12.16.3 Alvogen Influenza Drugs Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Alvogen Influenza Drugs Products Offered
12.16.5 Alvogen Recent Development
13 Influenza Drugs Manufacturing Cost Analysis
13.1 Influenza Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Influenza Drugs
13.4 Influenza Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Influenza Drugs Distributors List
14.3 Influenza Drugs Customers
15 Market Dynamics
15.1 Influenza Drugs Market Trends
15.2 Influenza Drugs Drivers
15.3 Influenza Drugs Market Challenges
15.4 Influenza Drugs Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
List of Tables
Table 1. Global Influenza Drugs Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027)
Table 2. Global Influenza Drugs Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027)
Table 3. Global Influenza Drugs Market Size (US$ Million) by Region: 2016 VS 2021 &2027
Table 4. Global Influenza Drugs Sales (K MT) by Region (2016-2021)
Table 5. Global Influenza Drugs Sales Market Share by Region (2016-2021)
Table 6. Global Influenza Drugs Revenue (US$ Million) Market Share by Region (2016-2021))
Table 7. Global Influenza Drugs Revenue Share by Region (2016-2021)
Table 8. Global Influenza Drugs Sales (K MT) Forecast by Region (2022-2027)
Table 9. Global Influenza Drugs Sales Market Share Forecast by Region (2022-2027)
Table 10. Global Influenza Drugs Revenue (US$ Million) Forecast by Region (2022-2027)
Table 11. Global Influenza Drugs Revenue Share Forecast by Region (2022-2027)
Table 12. Global Influenza Drugs Sales (K MT) of Key Companies (2016-2021)
Table 13. Global Influenza Drugs Sales Share by Company (2016-2021)
Table 14. Global Influenza Drugs Revenue (US$ Million) by Company (2016-2021)
Table 15. Global Influenza Drugs Revenue Share by Company (2016-2021)
Table 16. Global Influenza Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Drugs as of 2020)
Table 17. Global Influenza Drugs Average Price (USD/MT) of Key Company (2016-2021)
Table 18. Manufacturers Influenza Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Influenza Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Global Influenza Drugs Sales (K MT) by Type (2016-2021)
Table 22. Global Influenza Drugs Sales Share by Type (2016-2021)
Table 23. Global Influenza Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 24. Global Influenza Drugs Price (USD/MT) by Type (2016-2021)
Table 25. Global Influenza Drugs Sales Share by Type (2022-2027)
Table 26. Global Influenza Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 27. Global Influenza Drugs Revenue Share by Type (2022-2027)
Table 28. Global Influenza Drugs Price (USD/MT) by Type (2022-2027)
Table 29. Global Influenza Drugs Sales (K MT) by Application (2016-2021)
Table 30. Global Influenza Drugs Sales Share by Application (2016-2021)
Table 31. Global Influenza Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 32. Global Influenza Drugs Price (USD/MT) by Application (2016-2021)
Table 33. Global Influenza Drugs Sales (K MT) by Application (2022-2027)
Table 34. Global Influenza Drugs Sales Share by Application (2022-2027)
Table 35. Global Influenza Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 36. Global Influenza Drugs Revenue Share by Application (2022-2027)
Table 37. Global Influenza Drugs Price (USD/MT) by Application (2022-2027)
Table 38. North America Influenza Drugs Sales (K MT) by Company (2016-2021)
Table 39. North America Influenza Drugs Sales Market Share by Company (2016-2021)
Table 40. North America Influenza Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 41. North America Influenza Drugs Revenue Market Share by Company (2016-2021)
Table 42. North America Influenza Drugs Sales by Type (2016-2021) & (K MT)
Table 43. North America Influenza Drugs Sales Market Share by Type (2016-2021)
Table 44. North America Influenza Drugs Sales by Type (2022-2027) & (K MT)
Table 45. North America Influenza Drugs Sales Market Share by Type (2022-2027)
Table 46. North America Influenza Drugs Sales by Application (2016-2021) & (K MT)
Table 47. North America Influenza Drugs Sales Market Share by Application (2016-2021)
Table 48. North America Influenza Drugs Sales by Application (2022-2027) & (K MT)
Table 49. North America Influenza Drugs Sales Market Share by Application (2022-2027)
Table 50. Europe Influenza Drugs Sales (K MT) by Company (2016-2021)
Table 51. Europe Influenza Drugs Sales Market Share by Company (2016-2021)
Table 52. Europe Influenza Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 53. Europe Influenza Drugs Revenue Market Share by Company (2016-2021)
Table 54. Europe Influenza Drugs Sales by Type (2016-2021) & (K MT)
Table 55. Europe Influenza Drugs Sales Market Share by Type (2016-2021)
Table 56. Europe Influenza Drugs Sales by Type (2022-2027) & (K MT)
Table 57. Europe Influenza Drugs Sales Market Share by Type (2022-2027)
Table 58. Europe Influenza Drugs Sales by Application (2016-2021) & (K MT)
Table 59. Europe Influenza Drugs Sales Market Share by Application (2016-2021)
Table 60. Europe Influenza Drugs Sales by Application (2022-2027) & (K MT)
Table 61. Europe Influenza Drugs Sales Market Share by Application (2022-2027)
Table 62. China Influenza Drugs Sales (K MT) by Company (2016-2021)
Table 63. China Influenza Drugs Sales Market Share by Company (2016-2021)
Table 64. China Influenza Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 65. China Influenza Drugs Revenue Market Share by Company (2016-2021)
Table 66. China Influenza Drugs Sales by Type (2016-2021) & (K MT)
Table 67. China Influenza Drugs Sales Market Share by Type (2016-2021)
Table 68. China Influenza Drugs Sales by Type (2022-2027) & (K MT)
Table 69. China Influenza Drugs Sales Market Share by Type (2022-2027)
Table 70. China Influenza Drugs Sales by Application (2016-2021) & (K MT)
Table 71. China Influenza Drugs Sales Market Share by Application (2016-2021)
Table 72. China Influenza Drugs Sales by Application (2022-2027) & (K MT)
Table 73. China Influenza Drugs Sales Market Share by Application (2022-2027)
Table 74. Japan Influenza Drugs Sales (K MT) by Company (2016-2021)
Table 75. Japan Influenza Drugs Sales Market Share by Company (2016-2021)
Table 76. Japan Influenza Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 77. Japan Influenza Drugs Revenue Market Share by Company (2016-2021)
Table 78. Japan Influenza Drugs Sales by Type (2016-2021) & (K MT)
Table 79. Japan Influenza Drugs Sales Market Share by Type (2016-2021)
Table 80. Japan Influenza Drugs Sales by Type (2022-2027) & (K MT)
Table 81. Japan Influenza Drugs Sales Market Share by Type (2022-2027)
Table 82. Japan Influenza Drugs Sales by Application (2016-2021) & (K MT)
Table 83. Japan Influenza Drugs Sales Market Share by Application (2016-2021)
Table 84. Japan Influenza Drugs Sales by Application (2022-2027) & (K MT)
Table 85. Japan Influenza Drugs Sales Market Share by Application (2022-2027)
Table 86. Southeast Asia Influenza Drugs Sales (K MT) by Company (2016-2021)
Table 87. Southeast Asia Influenza Drugs Sales Market Share by Company (2016-2021)
Table 88. Southeast Asia Influenza Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 89. Southeast Asia Influenza Drugs Revenue Market Share by Company (2016-2021)
Table 90. Southeast Asia Influenza Drugs Sales by Type (2016-2021) & (K MT)
Table 91. Southeast Asia Influenza Drugs Sales Market Share by Type (2016-2021)
Table 92. Southeast Asia Influenza Drugs Sales by Type (2022-2027) & (K MT)
Table 93. Southeast Asia Influenza Drugs Sales Market Share by Type (2022-2027)
Table 94. Southeast Asia Influenza Drugs Sales by Application (2016-2021) & (K MT)
Table 95. Southeast Asia Influenza Drugs Sales Market Share by Application (2016-2021)
Table 96. Southeast Asia Influenza Drugs Sales by Application (2022-2027) & (K MT)
Table 97. Southeast Asia Influenza Drugs Sales Market Share by Application (2022-2027)
Table 98. India Influenza Drugs Sales (K MT) by Company (2016-2021)
Table 99. India Influenza Drugs Sales Market Share by Company (2016-2021)
Table 100. India Influenza Drugs Revenue by Company (2016-2021) & (US$ Million)
Table 101. India Influenza Drugs Revenue Market Share by Company (2016-2021)
Table 102. India Influenza Drugs Sales by Type (2016-2021) & (K MT)
Table 103. India Influenza Drugs Sales Market Share by Type (2016-2021)
Table 104. India Influenza Drugs Sales by Type (2022-2027) & (K MT)
Table 105. India Influenza Drugs Sales Market Share by Type (2022-2027)
Table 106. India Influenza Drugs Sales by Application (2016-2021) & (K MT)
Table 107. India Influenza Drugs Sales Market Share by Application (2016-2021)
Table 108. India Influenza Drugs Sales by Application (2022-2027) & (K MT)
Table 109. India Influenza Drugs Sales Market Share by Application (2022-2027)
Table 110. Bristol-Myers Squibb] Corporation Information
Table 111. Bristol-Myers Squibb] Description and Business Overview
Table 112. Bristol-Myers Squibb] Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 113. Bristol-Myers Squibb] Influenza Drugs Product
Table 114. Bristol-Myers Squibb] Recent Development
Table 115. AstraZeneca Corporation Information
Table 116. AstraZeneca Description and Business Overview
Table 117. AstraZeneca Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 118. AstraZeneca Influenza Drugs Product
Table 119. AstraZeneca Recent Development
Table 120. Eli Lilly Corporation Information
Table 121. Eli Lilly Description and Business Overview
Table 122. Eli Lilly Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 123. Eli Lilly Influenza Drugs Product
Table 124. Eli Lilly Recent Development
Table 125. Roche Corporation Information
Table 126. Roche Description and Business Overview
Table 127. Roche Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 128. Roche Influenza Drugs Product
Table 129. Roche Recent Development
Table 130. GlaxoSmithKline Corporation Information
Table 131. GlaxoSmithKline Description and Business Overview
Table 132. GlaxoSmithKline Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 133. GlaxoSmithKline Influenza Drugs Product
Table 134. GlaxoSmithKline Recent Development
Table 135. Novartis Corporation Information
Table 136. Novartis Description and Business Overview
Table 137. Novartis Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 138. Novartis Influenza Drugs Product
Table 139. Novartis Recent Development
Table 140. Pfizer Corporation Information
Table 141. Pfizer Description and Business Overview
Table 142. Pfizer Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 143. Pfizer Influenza Drugs Product
Table 144. Pfizer Recent Development
Table 145. Sanofi Pasteur Corporation Information
Table 146. Sanofi Pasteur Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 147. Sanofi Pasteur Description and Business Overview
Table 148. Sanofi Pasteur Influenza Drugs Product
Table 149. Sanofi Pasteur Recent Development
Table 150. Bayer Corporation Information
Table 151. Bayer Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 152. Bayer Description and Business Overview
Table 153. Bayer Influenza Drugs Product
Table 154. Bayer Recent Development
Table 155. Celgene Corporation Information
Table 156. Celgene Description and Business Overview
Table 157. Celgene Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 158. Celgene Influenza Drugs Product
Table 159. Celgene Recent Development
Table 160. Seqirus Corporation Information
Table 161. Seqirus Description and Business Overview
Table 162. Seqirus Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 163. Seqirus Influenza Drugs Product
Table 164. Seqirus Recent Development
Table 165. Protein Sciences Corporation Corporation Information
Table 166. Protein Sciences Corporation Description and Business Overview
Table 167. Protein Sciences Corporation Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 168. Protein Sciences Corporation Influenza Drugs Product
Table 169. Protein Sciences Corporation Recent Development
Table 170. Serum Institute of India Corporation Information
Table 171. Serum Institute of India Description and Business Overview
Table 172. Serum Institute of India Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 173. Serum Institute of India Influenza Drugs Product
Table 174. Serum Institute of India Recent Development
Table 175. Emergent Biosolutions Corporation Information
Table 176. Emergent Biosolutions Description and Business Overview
Table 177. Emergent Biosolutions Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 178. Emergent Biosolutions Influenza Drugs Product
Table 179. Emergent Biosolutions Recent Development
Table 180. BioCryst Pharmaceuticals Corporation Information
Table 181. BioCryst Pharmaceuticals Description and Business Overview
Table 182. BioCryst Pharmaceuticals Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 183. BioCryst Pharmaceuticals Influenza Drugs Product
Table 184. BioCryst Pharmaceuticals Recent Development
Table 185. Alvogen Corporation Information
Table 186. Alvogen Description and Business Overview
Table 187. Alvogen Influenza Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2016-2021)
Table 188. Alvogen Influenza Drugs Product
Table 189. Alvogen Recent Development
Table 190. Production Base and Market Concentration Rate of Raw Material
Table 191. Key Suppliers of Raw Materials
Table 192. Influenza Drugs Distributors List
Table 193. Influenza Drugs Customers List
Table 194. Influenza Drugs Market Trends
Table 195. Influenza Drugs Market Drivers
Table 196. Influenza Drugs Market Challenges
Table 197. Influenza Drugs Market Restraints
Table 198. Research Programs/Design for This Report
Table 199. Key Data Information from Secondary Sources
Table 200. Key Data Information from Primary Sources
List of Figures
Figure 1. Influenza Drugs Product Picture
Figure 2. Global Influenza Drugs Sales Market Share by Type in 2021 & 2027
Figure 3. Zanamivir Product Picture
Figure 4. Oseltamivir Phosphate Product Picture
Figure 5. Peramivir Product Picture
Figure 6. Other Influenza Drugs Product Picture
Figure 7. Global Influenza Drugs Sales Market Share by Application in 2021 & 2027
Figure 8. Adults Examples
Figure 9. Chidren Examples
Figure 10. Global Influenza Drugs Sales, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Influenza Drugs Sales Growth Rate (2016-2027) & (US$ Million)
Figure 12. Global Influenza Drugs Sales (K MT) Growth Rate (2016-2027)
Figure 13. Global Influenza Drugs Price Trends Growth Rate (2016-2027) (USD/MT)
Figure 14. Global Influenza Drugs Revenue Market Share by Region: 2016 VS 2021
Figure 15. Global Influenza Drugs Revenue Market Share by Region: 2021 VS 2027
Figure 16. North America Influenza Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 17. North America Influenza Drugs Sales (K MT) Growth Rate (2016-2027)
Figure 18. Europe Influenza Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 19. Europe Influenza Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 20. China Influenza Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 21. China Influenza Drugs Sales (Million USD) and Growth Rate (2016-2027)
Figure 22. Japan Influenza Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 23. Japan Influenza Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 24. Southeast Asia Influenza Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 25. Southeast Asia Influenza Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 26. India Influenza Drugs Revenue (Million USD) Growth Rate (2016-2027)
Figure 27. India Influenza Drugs Sales (Million USD) Growth Rate (2016-2027)
Figure 28. Global 5 Largest Influenza Drugs Players Market Share by Revenue in Influenza Drugs: 2016 & 2020
Figure 29. Influenza Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 30. Global Influenza Drugs Revenue Share by Type (2016-2021)
Figure 31. Global Influenza Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 32. Global Influenza Drugs Revenue Share by Application (2016-2021)
Figure 33. Global Influenza Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 34. North America Influenza Drugs Sales Market Share by Type in 2020
Figure 35. North America Influenza Drugs Sales Market Share by Application in 2020
Figure 36. Europe Influenza Drugs Sales Market Share by Type in 2020
Figure 37. Europe Influenza Drugs Sales Market Share by Application in 2020
Figure 38. China Influenza Drugs Sales Market Share by Type in 2020
Figure 39. China Influenza Drugs Sales Market Share by Application in 2020
Figure 40. Japan Influenza Drugs Sales Market Share by Type in 2020
Figure 41. Japan Influenza Drugs Sales Market Share by Application in 2020
Figure 42. Southeast Asia Influenza Drugs Sales Market Share by Type in 2020
Figure 43. Southeast Asia Influenza Drugs Sales Market Share by Application in 2020
Figure 44. India Influenza Drugs Sales Market Share by Type in 2020
  • Global Portable Veterinary X Ray System Sales Market Report 2021
    Published: 18-Jun-2021        Price: US 4000 Onwards        Pages: 146
    The global Portable Veterinary X Ray System market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Portable Veterinary X Ray System market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Digital - A......
  • Global Postpartum Bleeding Drug Sales Market Report 2021
    Published: 18-Jun-2021        Price: US 4000 Onwards        Pages: 134
    The global Postpartum Bleeding Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Postpartum Bleeding Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Oral - Injection ......
  • Global Autoantibody Kit Sales Market Report 2021
    Published: 18-Jun-2021        Price: US 4000 Onwards        Pages: 135
    The global Autoantibody Kit market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Autoantibody Kit market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Indirect Immunofluorescence (IIF) - Immunod......
  • Global Betahistine Sales Market Report 2021
    Published: 18-Jun-2021        Price: US 4000 Onwards        Pages: 131
    The global Betahistine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Betahistine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - 8mg - 25mg - Others Segment by ......
  • Global Fungal Foot Drugs Sales Market Report 2021
    Published: 18-Jun-2021        Price: US 4000 Onwards        Pages: 130
    The global Fungal Foot Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Fungal Foot Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Cream - Spray - Others ......
  • Global Foot Care Medicine Sales Market Report 2021
    Published: 18-Jun-2021        Price: US 4000 Onwards        Pages: 135
    The global Foot Care Medicine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Foot Care Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Cream - Spary Segment by......
  • Global DMSO Freezing Culture Media Sales Market Report 2021
    Published: 18-Jun-2021        Price: US 4000 Onwards        Pages: 146
    The global DMSO Freezing Culture Media market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global DMSO Freezing Culture Media market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Serum-Free Freezing Culture ......
  • Global DMSO-free Freezing Culture Media Sales Market Report 2021
    Published: 18-Jun-2021        Price: US 4000 Onwards        Pages: 144
    The global DMSO-free Freezing Culture Media market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global DMSO-free Freezing Culture Media market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - Serum-Free Freezin......
  • Global Serum Freezing Culture Media Sales Market Report 2021
    Published: 18-Jun-2021        Price: US 4000 Onwards        Pages: 145
    The global Serum Freezing Culture Media market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Serum Freezing Culture Media market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027. Segment by Type - With DMSO - DMSO-fr......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs